|
Oct 2
|
Top Midday Decliners
|
|
Oct 2
|
Shattuck Labs stock craters following pipeline and job cuts
|
|
Oct 2
|
STTK Discontinues Cancer Program, Plans Workforce Cut, Stock Falls
|
|
Oct 2
|
Shattuck Labs Refocuses Strategy Amidst Restructuring and Cuts
|
|
Oct 1
|
Shattuck Labs Shutters Cancer Program, Lays Off Around 40% Of Its Workforce, Reorganizes Pipeline
|
|
Oct 1
|
Shattuck Labs Provides Company Update and Announces SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist Targeting the TL1A/DR3 Signaling Pathway
|
|
Jul 30
|
Shattuck Labs Announces Participation in Upcoming BTIG Virtual Biotechnology Conference
|
|
Jun 14
|
Shattuck (STTK) Announces Positive Interim Data on Cancer Drug
|
|
Jun 14
|
Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid L...
|
|
Jun 10
|
Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FDA) for SL-172154 for the Treatment of Acute Myeloid Leukemia (AML)
|
|
May 14
|
Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at th...
|
|
May 7
|
What Makes Shattuck Labs (STTK) a New Buy Stock
|
|
May 7
|
Does Shattuck Labs (STTK) Have the Potential to Rally 34.17% as Wall Street Analysts Expect?
|
|
May 4
|
Shattuck Labs First Quarter 2024 Earnings: Beats Expectations
|
|
May 4
|
Shattuck Labs Inc (STTK) Reports First Quarter 2024 Financial Results
|
|
May 2
|
Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Tops Revenue Estimates
|
|
May 2
|
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights
|
|
Apr 18
|
Owning 36% shares,institutional owners seem interested in Shattuck Labs, Inc. (NASDAQ:STTK),
|
|
Apr 9
|
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
|
|
Apr 1
|
Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference
|